Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Pilger, E; Lammer, J; Bertuch, H; Steiner, H.
Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
Radiology. 1986; 161(3):597-599 Doi: 10.1148/radiology.161.3.3786705
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Leading authors Med Uni Graz
Pilger Ernst
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
In order to investigate and compare the fibrinolytic activity of streptokinase, streptokinase-Glutamine-plasminogen, and urokinase for intraarterial fibrinolysis, as in vitro test and a prospective trial were performed. For the in vitro demonstration of lytic activity, fibrin plates with plasminogen and fibrin plates without plasminogen were incubated with streptokinase; with streptokinase-plasminogen in molar proportions of 1:1, 1:2, and 2:1, and with urokinase. In order to examine the in vivo activity of the different lytic solutions, 98 patients suffering from peripheral arterial occlusions were divided into three homogeneous groups for treatment with streptokinase, streptokinase-plasminogen, and urokinase. Although urokinase was superior to streptokinase on the fibrin plate with plasminogen, no difference was demonstrated in vivo between the two lytic agents. Streptokinase-plasminogen in a molar proportion of 1:2 showed significantly higher fibrinolytic activity than any other solution. Therefore, the fibrinolytic agent of choice for intrathrombotic injections seems to be a 1:2 solution of streptokinase with plasminogen or with the lytic enzyme plasmin itself.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Arterial Occlusive Diseases - drug therapy
Drug Combinations - drug therapy
Female - drug therapy
Fibrinolytic Agents - therapeutic use
Humans - therapeutic use
Male - therapeutic use
Middle Aged - therapeutic use
Plasminogen - therapeutic use
Prospective Studies - therapeutic use
Streptokinase - therapeutic use
Urinary Plasminogen Activator - therapeutic use

© Med Uni GrazImprint